Kailera
Clinical trials sponsored by Kailera, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New weekly shot could help people with obesity shed pounds without diabetes Results expected May 2027 (estimated)
- New daily pill aims to shed pounds in obesity trial Results expected Jul 2027 (estimated)
-
New weekly shot could help millions shed pounds and control diabetes
Disease control Recruiting nowThis Phase 3 trial tests a new drug called KAI-9531, given as a weekly injection, in 1700 adults who are overweight or obese and have type 2 diabetes. The study compares KAI-9531 to a placebo to see if it leads to greater weight loss and better blood sugar control over 76 weeks. …
Phase 3 • Sponsor: Kailera • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New weekly shot could help shed pounds without diabetes
Disease control Recruiting nowThis study tests a new weekly injection called KAI-9531 to help people with obesity or overweight lose weight. It is for adults who do not have diabetes but have weight-related health problems like high blood pressure or sleep apnea. About 1800 participants will receive either th…
Phase 3 • Sponsor: Kailera • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New obesity drug aims to beat semaglutide in major trial
Disease control Recruiting nowThis study tests a new weekly injection called KAI-9531 to help people with obesity lose weight. It involves 1,200 adults who do not have diabetes and compares KAI-9531 to semaglutide (a known weight-loss drug) and a placebo. The main goal is to see how much weight participants l…
Phase 3 • Sponsor: Kailera • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC